DS
BEAM icon

DRW Securities’s Beam Therapeutics BEAM Stock Holding History

DRW Securities’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,997
Closed -$214K – 998
2026
Q1 		$214K Buy
+8,997
New +$250K ﹤0.01% 1072
2025
Q3 		– Sell
-13,896
Closed -$236K – 1297
2025
Q2 		$236K Buy
+13,896
New +$242K 0.01% 862

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

DRW Securities's BEAM Position: Q2 2026 in Review

DRW Securities sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 8,997 shares — an estimated $214K sold.

DRW Securities first reported a position in BEAM in Q2 2025 and held it in 2 quarters. The position peaked at $236K in Q2 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • DRW Securities reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 8,997 Beam Therapeutics shares in Q2 2026, an estimated $214K.
  • DRW Securities first reported a position in Beam Therapeutics in Q2 2025 and held it in 2 quarters.
  • DRW Securities's Beam Therapeutics position peaked at $236K in Q2 2025.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.